Take advantage of educational resources

Portrazza Resource Center

Access or order educational resources online. Visit the Resource Center to order today.

SQUIRE article

Presents the analyses and results of the SQUIRE trial, a randomized, multicenter, open-label, phase III, controlled trial of Portrazza (necitumumab) in combination with gemcitabine and cisplatin versus gemcitabine and cisplatin alone in patients receiving initial chemotherapy for their metastatic squamous NSCLC (N=1093). Use your The Lancet® login information to view the publication.

Lilly Medical

LillyMedical.com is available to all healthcare professionals in the US. This online resource offers Lilly product and medical information, including Prescribing Information, using a self-directed search. Visitors to the site can submit a question or chat with a Lilly Medical Professional. For more information, visit www.LillyMedical.com.

Portrazza Dosing and Administration Guide

Offers detailed information on recommended dose and schedule, premedication, dose modifications, and infusion preparation for Portrazza.

Portrazza Billing and Coding Guide

This guide contains applicable billing and coding information for Portrazza.

Key Information for Claims Submission

This guide contains helpful information, including proper HCPCS, CPT®, NDC, diagnosis codes, and billing units related to submitting claim forms for the administration of Portrazza.

CMS-1450 Sample Claim Form

This resource provides suggested guidance on how to populate the CMS-1450 claim form when submitting a claim for the administration of Portrazza in the outpatient hospital setting.

CMS-1500 Sample Claim Form

This resource provides suggested guidance on how to populate the CMS-1500 claim form when submitting a claim for the administration of Portrazza in the physician’s office.

The Lancet® is a registered trademark of Reed Elsevier Properties S.A.

CPT is a registered trademark of the American Medical Association.